Histopathological evaluation and expression of the pluripotent mesenchymal stem cell-like markers CD105 and CD44 in the synovial membrane of patients with primary versus secondary hip osteoarthritis.
To present the morphological changes of classic primary versus rapidly progressive and secondary hip osteoarthritis (HO) and to examine the expression of two pluripotent mesenchymal stem cell-like markers in the synovial membrane. A prospective observational study was conducted in 57 consecutive cases of radiologically confirmed HO in which total hip arthroplasty was performed. Based on the radiological and clinicopathological features, the cases were divided into three categories: classic primary HO (group A; n=16), rapidly destructive HO (group B; n=24), and HO secondary to avascular osteonecrosis of the femoral head (group C; n=17). Immunostains were performed using the markers CD44 and CD105. The cases from group A were mainly characterized by a marked perivascular inflammatory infiltrate and simple synovial hyperplasia. In group B, the papillary type of synovial hyperplasia was found and presence of chondromatosis, ossification, and ectopic follicles with germinal centers in the subsynovial layer was characteristic, whereas marked calcification and/or ossification were seen in group C. Focal expression of the CD105 and CD44 was noted in the hyperplastic synovial cells and subsynovial layer in cases from group A, whereas synovial cells from group B were diffusely positive for both CD44 and CD105. In secondary HO, CD44 marked the inflammatory cells. Mobilization of the CD44/CD105 positive synovial cells seems to play a role in the genesis of HO. The number of the pluripotent mesenchymal stem cell-like cells derived from the hyperplastic synovial cells might be related to the severity of possible immune-mediated rapidly destructive HO.
Department of Pathology, University of Medicine and Pharmacy, Tirgu-Mures, Romania.
Sabin Gligore
SG
Turdean
Department of Pathology, University of Medicine and Pharmacy, Tirgu-Mures, Romania.
Ioan
I
Jung
Department of Pathology, University of Medicine and Pharmacy, Tirgu-Mures, Romania.
Simona
S
Gurzu
Department of Orthopedics, University of Medicine and Pharmacy, Tirgu-Mures, Romania.
Ancuta
A
Zazgyva
Department of Pathology, University of Medicine and Pharmacy, Tirgu-Mures, Romania.
Annamaria
A
Fetyko
Department of Orthopedics, University of Medicine and Pharmacy, Tirgu-Mures, Romania.
Ciprian Oliviu
CO
Roman
Department of Pathology, University of Medicine and Pharmacy, Tirgu-Mures, Romania.
Mihai
M
Turcu
Department of Orthopedics, University of Medicine and Pharmacy, Tirgu-Mures, Romania.
Tudor Sorin
TS
Pop
D015415:Biomarkers / Q000378:metabolism; D000071063:Endoglin / Q000378:metabolism*; D005271:Femur Head Necrosis / Q000000981:diagnostic imaging / Q000473:pathology; D006801:Humans; D018960:Hyaluronan Receptors / Q000378:metabolism*; D059630:Mesenchymal Stem Cells / Q000378:metabolism*; D015207:Osteoarthritis, Hip / Q000000981:diagnostic imaging / Q000473:pathology*; D039904:Pluripotent Stem Cells / Q000378:metabolism*; D013583:Synovial Membrane / Q000378:metabolism*
D015415:Biomarkers; C497483:CD44 protein, human; D000071063:Endoglin; D018960:Hyaluronan Receptors
Osteoarthritis